Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, December 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Exiqon Launches Two New Research Use Only Kits
Friday, December 19, 2014
The miRSIGN™ miR-21 Oncogene assay and the miRSIGN™ Colon Cancer assay for PCR analysis of colon cancer samples.

Breaking Barriers in siRNA Delivery
Wednesday, December 17, 2014
Discover a new approach to transfection in the latest DECODED article from IDT.

Bio-Rad Introduces Bio-Plex Pro™ Human Inflammation Panels
Tuesday, December 16, 2014
Superior profiling of cancer, cardiovascular, and other disease biomarkers.

OSU Launches NGS Cancer Panels Using GO Clinical Workbench
Friday, November 28, 2014
Company’s GO Clinical Workbench™ to enable clinical reporting of mutations detected from NGS.

PGDx Launches CancerSelect™ Targeted Gene Panel for Patients and Physicians
Friday, November 14, 2014
Company is first to offer highly informative panel that targets the most actionable cancer genes and compares tumor and normal DNA.

PGDx Launches CancerSelect™ ES Providing Turnkey Solution
Friday, November 14, 2014
Enterprise solution package for labs includes panels targeting most relevant cancer genes, bioinformatics software, report generation, staff training, technical support and gene panel updates.

BioCision Announces Industry’s First Automated Biospecimen Thawing System
Wednesday, November 12, 2014
Intelligent device utilizes adaptive sensing technology for accurate and standardized thawing.

Quest Diagnostics Introduces BRCAvantage Plus™
Friday, November 07, 2014
First major service extension to the company's BRCAvantage™ BRCA1 and BRCA2 mutation test menu offers screening for five new non-BRCA genes shown to increase risk of inherited breast cancer.

EKF Molecular to Exhibit at AMP 2014
Friday, November 07, 2014
Senior executives on hand to discuss collaborative research with MGH aimed at developing routine blood based tests for cancer.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 667
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn